Ref: Harrison 18th/147 The current treatment of choice for malignant hypehermia is the intravenous administration of dantrolene other impoant measures are: *Discontinuation of triggering agents *Suppeive therapy directed at correcting hypehermia, acidosis, and organ dysfunction.